| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |